pubrio
AccessBio Korea

AccessBio Korea

South Korea · Hospital & Health Care

Medical Devices

Hospital & Health Care

Biotechnology

Healthcare

Access Bio Korea was established as a 100% subsidiary of Access Bio in the United States. Currently, rapid diagnostic kits are in the spotlight due to the global COVID-19 crisis, and we produce antibody/antigen identification diagnostic kits for COVID-19 as our main item. It also produces items from Wells Bio Co., Ltd., a subsidiary in Korea, and is sold worldwide in Asia, the Middle East, and Europe. In addition to products related to COVID-19, we produce Flu A&B and Dengue products as our main items. Our factory has acquired GMP and ISO and is constantly striving to improve productivity and quality.

Company Insights
Company Overview

2017

Founded

Hospital & Health Care

Industry

South Korea

Location

7,248,735

Ranking

4 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding AccessBio Korea

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​